ML

Marion Lanier

EP Escient Pharmaceuticals: 9 patents #7 of 7Top 100%
TL Takeda Pharmaceutical Company Limited: 5 patents #285 of 1,531Top 20%
NB Neurocrine Biosciences: 2 patents #68 of 128Top 55%
HI Human Biomolecular Research Institute: 1 patents #4 of 13Top 35%
SI Sanford-Burnham Medical Research Institute: 1 patents #61 of 162Top 40%
SL Smithkline Beecham (Cork) Limited: 1 patents #10 of 32Top 35%
Overall (All Time): #228,619 of 4,157,543Top 6%
19
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12384748 Modulators of mas-related g-protein receptor X2 and related products and methods Marcus F. Boehm, Liming Huang, Esther Martinborough, Marcos Sainz, Brandon Selfridge +1 more 2025-08-12
12275707 Modulators of mas-related g-protein receptor X2 and related products and methods Marcus F. Boehm, Liming Huang, Esther Martinborough, Marcos Sainz, Brandon Selfridge +1 more 2025-04-15
12240845 Modulators of mas-related G-protein receptor X2 and related products and methods Marcos Sainz, Marcus F. Boehm, Liming Huang, Esther Martinborough, Brandon Selfridge +1 more 2025-03-04
12129243 Modulators of Mas-related G-protein receptor X2 and related products and methods Marcus F. Boehm, Liming Huang, Esther Martinborough, Marcos Sainz, Brandon Selfridge +1 more 2024-10-29
12129244 Modulators of Mas-related G-protein receptor X2 and related products and methods Marcus F. Boehm, Liming Huang, Esther Martinborough, Marcos Sainz, Brandon Selfridge +1 more 2024-10-29
11970452 Modulators of mas-related G-protein receptor X2 and related products and methods Marcus F. Boehm, Liming Huang, Esther Martinborough, Marcos Sainz, Brandon Selfridge +1 more 2024-04-30
11952346 Modulators of mas-related G-protein receptor X2 and related products and methods Marcus F. Boehm, Liming Huang, Esther Martinborough, Marcos Sainz, Brandon Selfridge +1 more 2024-04-09
11919864 Modulators of Mas-related G-protein receptor X2 and related products and methods Marcus F. Boehm, Liming Huang, Esther Martinborough, Marcos Sainz, Brandon Selfridge +1 more 2024-03-05
11667636 Modulators of Mas-related G-protein receptor X2 and related products and methods Marcos Sainz, Marcus F. Boehm, Liming Huang, Esther Martinborough, Brandon Selfridge +1 more 2023-06-06
10407409 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD Jason W. Brown, Melinda Davis, Anthony Ivetac, Benjamin Jones, Andre A. Kiryanov +4 more 2019-09-10
9944626 6-(5-hydroxy-1H-pyrazol-1-YL)nicotinamide inhibitors of PHD Jason W. Brown, Melinda Davis, Anthony Ivetac, Benjamin Jones, Andre A. Kiryanov +4 more 2018-04-17
9708296 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD Jason W. Brown, Melinda Davis, Anthony Ivetac, Benjamin Jones, Andre A. Kiryanov +4 more 2017-07-18
9345713 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD Jason W. Brown, Melinda Davis, Anthony Ivetac, Benjamin Jones, Andre A. Kiryanov +4 more 2016-05-24
9233926 Compounds for stem cell differentiation Mark Mercola, John R. Cashman, Erik Willems, Dennis Schade 2016-01-12
9040522 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD Jason W. Brown, Melinda Davis, Anthony Ivetac, Benjamin Jones, Andre A. Kiryanov +4 more 2015-05-26
9023340 Wnt inhibitors for human stem cell differentiation John R. Cashman, Mark Mercola, Dennis Schade, Erik Willems 2015-05-05
7879862 Pyrazolo[1,5-alpha]pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists John Tellew, John Williams 2011-02-01
7652035 CRF receptor antagonists and methods relating thereto Manisha Moorjani, John Tellew, John Williams 2010-01-26
6747034 CRF receptor antagonists and methods relating thereto Mustapha Haddach, Charles Huang, James R. McCarthy 2004-06-08